204
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2633-2644 | Received 04 Jul 2023, Accepted 09 Nov 2023, Published online: 15 Nov 2023

References

  • GOLD comittee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report); 2022.
  • Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J COPD. 2015;10:95–109.
  • Vanfleteren LEGW, Fabbri LM. Self-management interventions in COPD patients with multimorbidity. Eur Respir J. 2019;54(5):1901850. doi:10.1183/13993003.01850-2019
  • Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221. doi:10.1002/gps.2463
  • Effing T, Lenferink A. Self-management: personalized action plans for COPD exacerbations. In: Enhancing Patient Engagement in Pulmonary Healthcare. The Art and Science; 2020:205–230.
  • Axson EL, Bottle A, Cowie MR, Quint JK. Relationship between heart failure and the risk of acute exacerbation of COPD. Thorax. 2021;76(8):807–814. doi:10.1136/thoraxjnl-2020-216390
  • Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J COPD. 2012;7:571–576.
  • Tinè M, Bazzan E, Semenzato U, et al. Heart failure is highly prevalent and difficult to diagnose in severe exacerbations of COPD presenting to the emergency department. J Clin Med. 2020;9(8):1–12. doi:10.3390/jcm9082644
  • Dos Santos NC, Miravitlles M, Camelier AA, De Almeida VD, Maciel RR, Camelier FWR. Prevalence and impact of comorbidities in individuals with COPD: a systematic review. Tuberc Respir Dis. 2022;85(3):205–220. doi:10.4046/trd.2021.0179
  • Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185(9):918–923. doi:10.1164/rccm.201105-0939PP
  • Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615–1631. doi:10.3978/j.issn.2072-1439.2014.09.28
  • Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J COPD. 2014;9:315–330. doi:10.2147/COPD.S53255
  • Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667–677. doi:10.1183/09031936.00125707
  • MacDonald MI, Shafuddin E, King PT, Chang CL, Bardin PG, Hancox RJ. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med. 2016;4(2):138–148. doi:10.1016/S2213-2600(15)00509-3
  • Sapey E, Bafadhel M, Bolton CE, Wilkinson T, Hurst JR, Quint JK. Building toolkits for COPD exacerbations: lessons from the past and present. Thorax. 2019;74(9):898–905. doi:10.1136/thoraxjnl-2018-213035
  • Lenferink A, Frith P, van der Valk P, et al. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol. Contemp Clin Trials. 2013;36(1):81–89. doi:10.1016/j.cct.2013.06.003
  • Lenferink A, van der Palen J, van der Valk PDLPM, et al. Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial. Eur Respir J. 2019;54(5):1802134. doi:10.1183/13993003.02134-2018
  • McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
  • Zigmond AS, Snalth RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Anthonisen NR, Manfreda J, Warren CPW, Hershfield E, Harding GKM, Nelson NA. Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196
  • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5 Suppl 2):398S–401S. doi:10.1378/chest.117.5_suppl_2.398S
  • Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–246. doi:10.1177/1098214005283748
  • Leong P, MacDonald MI, King PT, et al. Treatable cardiac disease in hospitalised COPD exacerbations. ERJ Open Res. 2021;7(1):00756–2020. doi:10.1183/23120541.00756-2020
  • Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673–678. doi:10.1503/cmaj.091784
  • Marsh S, Guck TP. Anxiety and depression: easing the burden in COPD patients. J Fam Pract. 2016;65(4):246–256.
  • Wen-tao D, Xue-xiu C, Zun-jiang C, Wei C, Cheng-feng P, Xing-ken F. The relationship between hospitalization frequency of acute exacerbation of chronic obstructive pulmonary disease and anxiety and depression. Front Genet. 2022;13:817727. doi:10.3389/fgene.2022.817727
  • Hogea SP, Tudorache E, Fildan AP, Fira-Mladinescu O, Marc M, Oancea C. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin Respir J. 2020;14(3):183–197. doi:10.1111/crj.13129
  • Angaran P, Dorian P, Ha AC, et al. Association of left ventricular ejection fraction with mortality and hospitalizations. J Am Soc Echocardiogr. 2020;33(7):802–811. doi:10.1016/j.echo.2019.12.016
  • Ahmed A, Aronow WS, Fleg JL. Higher New York Heart association classes and increased mortality and hospitalization in heart failure patients with preserved left ventricular function. Bone. 2006;151(2):444–450.
  • Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139. doi:10.1093/eurjhf/hfn013
  • Čelutkienė J, Balčiūnas M, Kablučko D, Vaitkevičiūte L, Vaitkevičiūte JB, Danila E. Challenges of treating acute heart failure in patients with Chronic Obstructive Pulmonary Disease. Card Fail Rev. 2017;3(1):56. doi:10.15420/cfr.2016:23:2
  • Ukena C, Mahfoud F, Kindermann M, et al. The cardiopulmonary continuum systemic inflammation as “common soil” of heart and lung disease. Int J Cardiol. 2010;145(2):172–176. doi:10.1016/j.ijcard.2010.04.082
  • Kalin NH. The critical relationship between anxiety and depression. Am J Psychiatry. 2020;177(5):365–367. doi:10.1176/appi.ajp.2020.20030305
  • McElroy E, Fearon P, Belsky J, Fonagy P, Patalay P. Networks of depression and anxiety symptoms across development. J Am Acad Child Adolesc Psychiatry. 2018;57(12):964–973. doi:10.1016/j.jaac.2018.05.027
  • Cafarella PA, Effing TW, Usmani ZA, Frith PA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology. 2012;17(4):627–638. doi:10.1111/j.1440-1843.2012.02148.x
  • Powers TL, Bendall D. Improving health outcomes through patient empowerment. J Hosp Mark Public Relat. 2003;15(1):45–59. doi:10.1300/J375v15n01_05
  • Kaehne A. Care integration – from “one size fits all” to person centred care: comment on “achieving integrated care for older people: shuffling the deckchairs or making the system watertight for the future? Int J Health Policy Manag. 2018;7(10):955–957. doi:10.15171/ijhpm.2018.51
  • Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018;27(149):180057. doi:10.1183/16000617.0057-2018
  • Hawkins NM, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J. 2013;34(36):2795–2803. doi:10.1093/eurheartj/eht192
  • Leidy NK, Sexton CC, Jones PW, et al. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014;69(5):443–449. doi:10.1136/thoraxjnl-2013-204428